Pregnancy Related Clinical Trial
Official title:
Pregnancy Massage and Mindfulness Study for Tobacco Smoking Women
Verified date | January 2020 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This trial will examine the contribution of massage therapy and mindfulness to tobacco-smoking women in the third trimester of pregnancy.
Status | Terminated |
Enrollment | 12 |
Est. completion date | January 24, 2020 |
Est. primary completion date | January 24, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - currently pregnant in third trimester - singleton pregnancy - aged 18 years or older - women smoked before their pregnancy - women who currently smoke at least 5 cigarettes per day at enrollment - women need access to a smartphone - women expressing an interest in learning skills to help decrease tobacco-smoking Exclusion Criteria: - incapable of giving informed consent - insufficient English fluency - participating in other smoking cessation programs - evidencing severe psychiatric symptoms |
Country | Name | City | State |
---|---|---|---|
United States | Yale Child Study Center | New Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University | Massage Therapy Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | CO (carbon monoxide) monitoring Change from Baseline to Post-Intervention | breath test | Up to 4 weeks | |
Other | MINI (Mini International Neuropsychiatric Interview) Substance Dependence | determine other substance use disorders | Enrollment | |
Other | Self-Reported Mood at each Massage Therapy Session for Intervention Group | positive and negative mood, including stress | Up to 3 weeks | |
Other | Mind-mindedness related to infant | Describe your child measure; this will be a narrative statement provided by participants where they are asked to describe their child. These narratives will be scored to ascertain the total number of mind-minded comments included in the narrative. | Up to 2 months | |
Primary | Tobacco Use Change from Baseline to Post-Intervention | Number of cigarettes smoked in past 24 hours | Up to 4 weeks | |
Primary | Withdrawal Symptoms Change from Baseline to Post-Intervention | Mood and Physical Symptoms Scale | Up to 4 weeks | |
Primary | Nicotine Dependence Change from Baseline to Post-Intervention | FTND (Fagerstrom Test for Nicotine Dependence) measure | Up to 4 weeks | |
Primary | Depression Change from Baseline to Post-Intervention | EPDS (Edinburgh Postnatal Depression Scale) measure | Up to 4 weeks | |
Primary | Anxiety Change from Baseline to Post-Intervention | Beck Anxiety Inventory | Up to 4 weeks | |
Primary | Stress Change from Baseline to Post-Intervention | Perceived Stress Scale | Up to 4 weeks | |
Primary | Daily Stress Scores Change from Baseline to Post-Intervention | Diary Measure | Up to 4 weeks | |
Primary | Daily Tobacco Usage Change from Baseline to Post-Intervention | Diary Measure | Up to 4 weeks | |
Primary | Heart Rate Variability Change from Baseline to Post-Intervention | Maternal heart rate variability measured at rest | Up to 4 weeks | |
Secondary | Neonatal Outcomes | mode of delivery (including any complications), infant well-being, gestational age, and weight. | Up to 2 months | |
Secondary | Fetal Heart Rate Change from Baseline to Post-Intervention | Fetal heart rate measured at rest | Up to 4 weeks | |
Secondary | Engagement with Craving to Quit | Engagement with the Craving to Quit app | Up to 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |